Literature DB >> 15231506

Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of delta-opioid receptor.

Shinji Okubo1, Yujirou Tanabe, Kenji Takeda, Michihiko Kitayama, Seiyu Kanemitsu, Rakesh C Kukreja, Noboru Takekoshi.   

Abstract

We examined whether ischemic preconditioning (IPC) attenuates ischemia-reperfusion injury, in part, by decreasing apoptosis and whether the delta-opioid receptor (DOR) plays a pivotal role in the regulation of apoptosis. Rabbits were subjected to 30-min coronary artery occlusion (CAO) and 180 min of reperfusion. IPC was elicited with four cycles of 5-min ischemia and 10-min reperfusion before CAO. Morphine (0.3 mg/kg iv) was given 15 min before CAO. Naloxone (Nal; 10 mg/kg iv) and naltrindole (Nti; 10 mg/kg iv), the respective nonselective and selective DOR antagonists were given 10 min before either morphine or IPC. Infarct size (%risk area) was reduced from 46 +/- 3.8 in control to 11.6 +/- 1.0 in IPC and 19.5 +/- 3.8 in the morphine group (means +/- SE; P < 0.001 vs. control). Nal blocked the protective effects of IPC and morphine, as shown by the increase in infarct size to 38.6 +/- 7.2 and 44.5 +/- 1.8, respectively. Similarly, Nti blocked IPC and morphine-induced protection. The percentage of apoptotic cells (revealed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay) decreased in IPC (3.6 +/- 1.9) and morphine groups (5.2 +/- 1.2) compared with control group (12.4 +/- 1.6; P < 0.001). Nti pretreatment increased apoptotic cells 11.2 +/- 2.2% in IPC and 12.1 +/- 0.8% in morphine groups. Nal failed to block inhibition of apoptosis in the IPC group (% of cells: 5.7 +/- 1.3 vs. 3.6 +/- 1.9 in IPC alone; P > 0.05). These results were also confirmed by nucleosomal DNA laddering pattern. We conclude that IPC reduces lethal injury, in part, by decreasing apoptosis after ischemia-reperfusion and activation of the DOR may play a crucial role in IPC or morphine-induced myocardial protection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231506     DOI: 10.1152/ajpheart.01143.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

1.  Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.

Authors:  Li-Jie Liu; Jian-Jun Yu; Xiao-Lin Xu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia.

Authors:  Beibei Xu; Joshua Strom; Qin M Chen
Journal:  Eur J Pharmacol       Date:  2011-06-25       Impact factor: 4.432

3.  Adverse cardiac events associated with incident opioid drug use among older adults with COPD.

Authors:  Nicholas T Vozoris; Xuesong Wang; Peter C Austin; Douglas S Lee; Anne L Stephenson; Denis E O'Donnell; Sudeep S Gill; Paula A Rochon
Journal:  Eur J Clin Pharmacol       Date:  2017-06-29       Impact factor: 2.953

4.  Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit.

Authors:  Farzaneh Rostami; Shahrbanoo Oryan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  J Mol Neurosci       Date:  2012-03-03       Impact factor: 3.444

Review 5.  Opioid-induced cardioprotection.

Authors:  Katsuya Tanaka; Judy R Kersten; Matthias L Riess
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats.

Authors:  Sascha Treskatsch; Aarne Feldheiser; Mohammed Shaqura; Lukas Dehe; Helmut Habazettl; Torsten K Röpke; Mehdi Shakibaei; Michael Schäfer; Claudia D Spies; Shaaban A Mousa
Journal:  Heart Vessels       Date:  2015-01-01       Impact factor: 2.037

7.  Protective effect of agmatine on a reperfusion model after transient cerebral ischemia: Temporal evolution on perfusion MR imaging and histopathologic findings.

Authors:  D J Kim; D I Kim; S K Lee; S H Suh; Y J Lee; J Kim; T S Chung; J E Lee
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

8.  Do We Really Need Aspirin Loading for STEMI?

Authors:  Regina Ye; Hani Jneid; Mahboob Alam; Barry F Uretsky; Dan Atar; Masafumi Kitakaze; Sean M Davidson; Derek M Yellon; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-16       Impact factor: 3.727

Review 9.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

10.  Kappa-opioid receptor activation during reperfusion limits myocardial infarction via ERK1/2 activation in isolated rat hearts.

Authors:  June Hong Kim; Young Ho Jang; Kook Jin Chun; Jun Kim; Yong Hyun Park; Jeong Su Kim; Jin Mo Kim; Mi Young Lee
Journal:  Korean J Anesthesiol       Date:  2011-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.